{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:51:55Z","timestamp":1788306715797,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["by Cooperative Agreement Number: NU50CK000423. Provided cost of PCR testing."],"award-info":[{"award-number":["by Cooperative Agreement Number: NU50CK000423. Provided cost of PCR testing."]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dengue virus (DENV) is endemic in many parts of the world. Antibody dependent enhancement (ADE) in DENV infections occurs when a person with primary immunity is infected by a second, different DENV strain. Antibodies to Zika virus (ZIKV), which emerged in the Western Hemisphere in 2015, are cross reactive with DENV and theoretically could provoke ADE in a DENV na\u00efve individual.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>DENV infection was suspected in a child who had recently returned from a one-month stay in the Dominican Republic. The child presented with fever, vomiting, abdominal pain, and in hypovolemic shock. Volume and pressor resuscitation were unsuccessful, and the child died less than 24\u00a0h after hospitalization. Laboratory results suggested an early acute first DENV infection since serum, plasma, and spinal fluid had DENV1 detected by polymerase chain reaction (PCR), yet the serum lacked IgG antibodies to DENV nonstructural protein 1 (NS1) of all four DENV serotypes. This acute DENV infection occurred in the presence of a remote ZIKV infection as determined by antibodies to ZIKV NS1 envelope by multiplex microsphere immunoassay and an exceptionally high plaque reduction neutralization titer to ZIKV. ZIKV IgG avidity index was high, confirming a past infection. DENV1 RNA was detected in all ten organs and tissues examined by PCR. The severe and fatal complications reported here suggest that a remote ZIKV infection may provoke an exaggerated immune response leading to hypovolemic shock when primarily infected by DENV1.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report the first known patient in the United States with a rapidly progressive and fatal case of travel-associated DENV in which prior exposure to ZIKV likely played a role in triggering an ADE phenomenon. This association of prior ZIKV immunity and subsequent new dengue infection is a worrisome phenomenon and an important contribution to the body of knowledge on immunity to flaviviruses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06482-0","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T07:02:52Z","timestamp":1628060572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection"],"prefix":"10.1186","volume":"21","author":[{"given":"Ashley N.","family":"Bonheur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Soshnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"McGibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Alan P.","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Slavinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula E.","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5898-4565","authenticated-orcid":false,"given":"Don","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle T.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Folkerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Laib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"6482_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504\u20137 (PMID: 23563266).","journal-title":"Nature"},{"key":"6482_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1128\/CMR.11.3.480","volume":"11","author":"DJ Gubler","year":"1998","unstructured":"Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480\u201396 (PMID: 9665979).","journal-title":"Clin Microbiol Rev"},{"key":"6482_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2017.42","volume":"6","author":"L Priyamvada","year":"2017","unstructured":"Priyamvada L, Hudson W, Ahmed R, Wrammert J. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Emerging Microbes Infect. 2017;6:1\u20136 (PMID: 28487557).","journal-title":"Emerging Microbes Infect"},{"key":"6482_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2019.02.001","volume":"59","author":"J Wen","year":"2019","unstructured":"Wen J, Shresta S. Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? Curr Opin Immunol. 2019;59:1\u20138 (PMID: 30884384).","journal-title":"Curr Opin Immunol"},{"key":"6482_CR5","doi-asserted-by":"crossref","unstructured":"Langerak T, Mumtaz N, Tolk VI, van Gorp ECM, Martina BE, Rockx B, et al. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis. PLoS Pathog. 2019;15(4):e1007640 (PMID: 30998804).","DOI":"10.1371\/journal.ppat.1007640"},{"key":"6482_CR6","doi-asserted-by":"crossref","unstructured":"Halstead S. Recent advances in understanding dengue. F1000Research. 2019; (F100FacultyRev):1279 Last updated:31JULY 2019. (PMID: 31448083)","DOI":"10.12688\/f1000research.19197.1"},{"key":"6482_CR7","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/JVI.01805-15","volume":"90","author":"SA Smith","year":"2015","unstructured":"Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, et al. Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single immunodominant antigenic site. J Virol. 2015;90:780\u20139 (PMID: 26512092).","journal-title":"J Virol"},{"key":"6482_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","volume":"60","author":"SB Halstead","year":"2003","unstructured":"Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res. 2003;60:421\u201346 (PMID: 14689700).","journal-title":"Adv Virus Res"},{"key":"6482_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.15585\/mmwr.mm6502a4","volume":"65","author":"D Johnston","year":"2016","unstructured":"Johnston D, Viray M, Ushiroda J, Whelen AC, Sciulli R, Remedios G, et al. Notes from the field: outbreak of locally acquired cases of dengue fever\u2014Hawaii, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:34\u20135 (PMID: 26796994).","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6482_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/insects5040991","volume":"5","author":"JR Rey","year":"2014","unstructured":"Rey JR. Dengue in Florida (USA). Insects. 2014;5:991\u20131000 (PMID: 26462955).","journal-title":"Insects"},{"issue":"835\u2013845","key":"6482_CR11","first-page":"24107180","volume":"13","author":"KO Murray","year":"2013","unstructured":"Murray KO, Rodriguez LF, Herrington E, Kharat V, Vasilakis N, Walker C, et al. Identification of dengue fever cases in Houston, Texas with evidence of autochthonous transmission between 2003 and 2005. Vector-borne Zoonotic Dis. 2013;13(835\u2013845):24107180.","journal-title":"Vector-borne Zoonotic Dis"},{"issue":"15","key":"6482_CR12","first-page":"41","volume":"64","author":"Centers for Disease Control and Prevention","year":"2017","unstructured":"Centers for Disease Control and Prevention. Summary of notifiable diseases and conditions\u2014United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;64(15):41.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"6482_CR13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1126\/science.aaf5036","volume":"352","author":"NR Faria","year":"2016","unstructured":"Faria NR, do Socorro da Silva Azevedo R, Kraemer MUG, Souza R, Cunha MS, Hill SC, et al. Zika virus in the Americas: early epidemiological and genetic findings. Science. 2016;352:345\u20139 (PMID: 27013429).","journal-title":"Science"},{"issue":"7","key":"6482_CR14","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1371\/journal.pntd.0002311","volume":"7","author":"GA Santiago","year":"2013","unstructured":"Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, Medina JF, et al. Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLOS Negl Trop Dis. 2013;7(7):2311 (PMID: 23875046).","journal-title":"PLOS Negl Trop Dis"},{"key":"6482_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1128\/JCM.01232-16","volume":"55","author":"K St. George","year":"2017","unstructured":"St. George K, Sohi IS, Dufort EM, Dean AB, White JL, Limberger R, et al. Zika virus testing considerations: lessons learned from the first 80 real-time reverse transcription-PCR-positive cases diagnosed in New York State. J Clin Microbiol. 2017;55:535\u201344 (PMID: 27927917).","journal-title":"J Clin Microbiol"},{"key":"6482_CR16","doi-asserted-by":"crossref","unstructured":"Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, Velez JO, Lambert AJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis. 2007; 13(5): 764\u2013767. (PMID: 17553261)","DOI":"10.3201\/eid1305.070015"},{"key":"6482_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ebiom.2017.01.008","volume":"16","author":"SJ Wong","year":"2017","unstructured":"Wong SJ, Furuya A, Zou J, Xie X, Dupuis AP, Kramer LD, et al. A multiplex microsphere immunoassay for Zika Virus diagnosis. EBioMedicine. 2017;16:136\u201340 (PMID: 28094237).","journal-title":"EBioMedicine"},{"key":"6482_CR18","first-page":"e01591","volume":"56","author":"WT Lee","year":"2017","unstructured":"Lee WT, Wong SJ, Kulas KE, Dupuis AP, Payne AF, Kramer LD, et al. Development of Zika virus serological testing strategies in New York State. J Clin Microbiol. 2017;56:e01591-e1617 (PMID: 29263203).","journal-title":"J Clin Microbiol"},{"issue":"4","key":"6482_CR19","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1128\/JCM.42.4.1782-1784.2004","volume":"42","author":"VAUF deSouza","year":"2004","unstructured":"deSouza VAUF, Fernades S, Araujo ES, Tateno AF, Oliveira ONMPF, dos Reis Oliveira R, et al. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J Clin Micro. 2004;42(4):1782\u20134 (PMID: 15071049).","journal-title":"J Clin Micro"},{"issue":"1","key":"6482_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1128\/CVI.13.1.33-36.2006","volume":"13","author":"JL Fox","year":"2006","unstructured":"Fox JL, Hazell SL, Tobler LH, Busch MP. Immunoglobulin G avidity in differentiation between early and late antibody responses to west Nile virus. Clin Vaccine Immunol. 2006;13(1):33\u20136 (PMID: 16425997).","journal-title":"Clin Vaccine Immunol"},{"issue":"April 4","key":"6482_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1042\/CS20180874","volume":"133","author":"AKM Furuya","year":"2019","unstructured":"Furuya AKM, Hunt D, St. George KS, Dupuis AP, Kramer LD, Shi PY, et al. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections. Clin Sci (Lond). 2019;133(April 4):859\u201367 (PMID: 30902827).","journal-title":"Clin Sci (Lond)"},{"issue":"27","key":"6482_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996;381(27):751\u20138 (PMID: 8657279).","journal-title":"Nature"},{"issue":"7","key":"6482_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.it.2017.04.003","volume":"38","author":"CT Watson","year":"2017","unstructured":"Watson CT, Glanville J, Marasco WA. The individual and population dynamics of antibody immunity. Trends Immunol. 2017;38(7):459\u201370. https:\/\/doi.org\/10.1016\/j.it.2017.04.003.","journal-title":"Trends Immunol"},{"issue":"3","key":"6482_CR24","first-page":"270","volume":"21","author":"MG Guzman","year":"1987","unstructured":"Guzman MG, Kouri G, Martinez E, Bravo J, Riveron R, Soler M, et al. Clinical and serologic study of Cuban children with dengue hemorrhagic fever\/dengue shock syndrome. PAHO Bulletin. 1987;21(3):270\u20139 (PMID: 3442718).","journal-title":"PAHO Bulletin"},{"key":"6482_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick LC, Gresh L, Halloran EM, Mercado JC, Kuan G, Gordon A, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358:929\u201332 (PMID: 29097492).","journal-title":"Science"},{"issue":"4","key":"6482_CR26","first-page":"375","volume":"67","author":"GP Kouri","year":"1989","unstructured":"Kouri GP, Guzman MG, Bravo JR, Triana C. Dengue haemorrhagic fever\/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull WHO. 1989;67(4):375\u201380 (PMID: 2805215).","journal-title":"Bull WHO"},{"issue":"13","key":"6482_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegro","year":"2015","unstructured":"Hadinegro SR, Arrendondo JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. New Eng J Med. 2015;373(13):1195\u2013206 (PMID: 26214039).","journal-title":"New Eng J Med"},{"key":"6482_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jclinepi.2017.11.019","volume":"95","author":"AL Dans","year":"2018","unstructured":"Dans AL, Dans LF, Lansang MAD, Silvestre MAA, Guyatt GH. Controversy and debate on dengue vaccine series\u2014paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs. J Clin Epi. 2018;95:137\u20139 (PMID: 29180056).","journal-title":"J Clin Epi"},{"key":"6482_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/JBM.S46255","volume":"5","author":"MR George","year":"2014","unstructured":"George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69\u201386 (PMID: 24966707).","journal-title":"J Blood Med"},{"issue":"8","key":"6482_CR30","doi-asserted-by":"publisher","first-page":"0004939","DOI":"10.1371\/journal.pntd.0004939","volume":"10","author":"EM Ellis","year":"2016","unstructured":"Ellis EM, Sharp TM, Perez-Padilla J, Gonzalez L, Poole-Smith BK, Lebo E, et al. Incidence and risk factors for developing dengue-associated hemophagocytic lymphohistiocytosis in Puerto Rico, 2008\u20132013. PLoS Negl Trop Dis. 2016;10(8):0004939 (PMID: 27556807).","journal-title":"PLoS Negl Trop Dis"},{"key":"6482_CR31","doi-asserted-by":"publisher","first-page":"27929","DOI":"10.1002\/pbc.27929","volume":"66","author":"MB Jordan","year":"2019","unstructured":"Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A, et al. Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatr Blood Cancer. 2019;66:27929 (PMID: 31339233).","journal-title":"Pediatr Blood Cancer"},{"key":"6482_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-019-00299-3","author":"X Xu","year":"2019","unstructured":"Xu X, Tang Y. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children. World J Pediatr. 2019. https:\/\/doi.org\/10.1007\/s12519-019-00299-3 (PMID: 31506890).","journal-title":"World J Pediatr"},{"key":"6482_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","volume":"24","author":"AM Fowler","year":"2018","unstructured":"Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, et al. Maternally acquired Zika antibodies enhance dengue disease severity in mice. Cell Host Microbe. 2018;24:743\u201350 (PMID: 30439343).","journal-title":"Cell Host Microbe"},{"key":"6482_CR34","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","volume":"7","author":"J George","year":"2017","unstructured":"George J, Valiant WG, Mattapalli MJ, Walker M, Huang YJS, Vanlandingham DL, et al. Prior exposure to Zika virus significantly enhances peak dengue-2 viremeia in rhesus macaques. Sci Rep. 2017;7:10498 (PMID: 28874759).","journal-title":"Sci Rep"},{"key":"6482_CR35","first-page":"e140","volume":"6","author":"GS Ribeiro","year":"2018","unstructured":"Ribeiro GS, Kikuti M, Tauro LB, Nascimento LCJ, Cardoso CW, Campos GS, et al. Does immunity after Zika virus infection cross-protect against dengue? Lancet. 2018;6:e140-141 (PMID: 29389533).","journal-title":"Lancet"},{"key":"6482_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fcimb.2018.00044","volume":"8","author":"MA Martin-Acebes","year":"2018","unstructured":"Martin-Acebes MA, Saiz JC, Jimenez de Oya N. Antibody-dependent enhancement and Zika: real threat or phantom menace? Front Cell Infect Microbiol. 2018;8:44 (PMID: 29497604).","journal-title":"Front Cell Infect Microbiol"},{"key":"6482_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","volume":"369","author":"LC Katzelnick","year":"2020","unstructured":"Katzelnick LC, Navarez C, Arguello S, Mercado BL, Collado D, Amoie O, et al. Zika virus enhances future risk of severe dengue disease. Science. 2020;369:1123\u20138.","journal-title":"Science"},{"key":"6482_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ebiom.2015.07.002","volume":"2","author":"A Mullings","year":"2015","unstructured":"Mullings A, Reid ME, Sang MM, Richards-Dawson MA, Knight-Madden JM. A retrospective analysis of the significance of haemoglobin SS and SC in disease outcome in patients with sickle cell disease and dengue fever. EBioMedicine. 2015;2:937\u201341 (PMID: 26425701).","journal-title":"EBioMedicine"},{"key":"6482_CR39","doi-asserted-by":"crossref","unstructured":"Elenga N, Celicourt D, Muanza B, Elana G, Hocquelet S, Tarer V, et al. Dengue in hospitalized children with sickle cell disease: a retrospective cohort study in the French departments of America. J Inf Pub Health. 2019.","DOI":"10.1016\/j.jiph.2019.07.015"},{"key":"6482_CR40","unstructured":"World Health Organization. Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and expanded edition. 2011. https:\/\/apps.who.int\/iris\/handle\/10665\/204894."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T07:03:07Z","timestamp":1628060587000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6482"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06482-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was submitted to the New York State Department of Health Institutional Review Board and was exempted from review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from the patient\u2019s next of kin for publication of case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"749"}}